Shuangsuo Dang

800 total citations
43 papers, 523 citations indexed

About

Shuangsuo Dang is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Shuangsuo Dang has authored 43 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 14 papers in Epidemiology and 12 papers in Molecular Biology. Recurrent topics in Shuangsuo Dang's work include Hepatitis C virus research (12 papers), Liver Disease Diagnosis and Treatment (9 papers) and Viral Infections and Immunology Research (8 papers). Shuangsuo Dang is often cited by papers focused on Hepatitis C virus research (12 papers), Liver Disease Diagnosis and Treatment (9 papers) and Viral Infections and Immunology Research (8 papers). Shuangsuo Dang collaborates with scholars based in China, United States and Japan. Shuangsuo Dang's co-authors include Xiaoli Jia, Wenjun Wang, Xin Zhang, Yaping Li, Juanjuan Shi, Robin L. Haynes, William T. Gerthoffer, Ilia A. Yamboliev, Jing Zhang and Chunhong Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Shuangsuo Dang

37 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuangsuo Dang China 12 202 161 126 115 48 43 523
Wafaa M. Ezzat Egypt 13 159 0.8× 204 1.3× 191 1.5× 152 1.3× 35 0.7× 43 526
Jianhong Chen China 16 188 0.9× 208 1.3× 81 0.6× 67 0.6× 71 1.5× 58 680
Kohei Oda Japan 14 151 0.7× 240 1.5× 168 1.3× 50 0.4× 81 1.7× 46 521
Ruoting Men China 17 229 1.1× 262 1.6× 256 2.0× 134 1.2× 85 1.8× 37 664
Chao Ou China 14 219 1.1× 88 0.5× 59 0.5× 72 0.6× 46 1.0× 32 488
Qiang Ji China 16 257 1.3× 125 0.8× 91 0.7× 119 1.0× 109 2.3× 57 674
Wei-Hong Yang China 13 425 2.1× 99 0.6× 62 0.5× 64 0.6× 74 1.5× 30 671
José María Vera-Cruz Mexico 10 124 0.6× 282 1.8× 250 2.0× 47 0.4× 25 0.5× 13 563
Xiaohui Tian China 11 241 1.2× 83 0.5× 60 0.5× 202 1.8× 97 2.0× 23 479
Kotaro Kumagai Japan 16 186 0.9× 390 2.4× 226 1.8× 51 0.4× 158 3.3× 59 791

Countries citing papers authored by Shuangsuo Dang

Since Specialization
Citations

This map shows the geographic impact of Shuangsuo Dang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuangsuo Dang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuangsuo Dang more than expected).

Fields of papers citing papers by Shuangsuo Dang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuangsuo Dang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuangsuo Dang. The network helps show where Shuangsuo Dang may publish in the future.

Co-authorship network of co-authors of Shuangsuo Dang

This figure shows the co-authorship network connecting the top 25 collaborators of Shuangsuo Dang. A scholar is included among the top collaborators of Shuangsuo Dang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuangsuo Dang. Shuangsuo Dang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Jianxia, Shan Ren, Ping Wu, et al.. (2025). Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon. Hepatology International. 19(6). 1331–1346.
2.
Li, Yaping, et al.. (2025). Effectiveness and Safety of Tenofovir Amibufenamide in the Treatment of Chronic Hepatitis B: A Real-world, Multicenter Study. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 1 indexed citations
3.
4.
Li, Yaping, et al.. (2024). Hepatitis B cure: Current situation and prospects. World Journal of Hepatology. 16(6). 900–911.
5.
Zhou, Xiaqing, Yaping Li, & Shuangsuo Dang. (2024). Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy. World Journal of Hepatology. 16(2). 164–176. 7 indexed citations
6.
Dang, Shuangsuo, et al.. (2023). The value of T2-weighted MRI contrast ratio combined with DWI in evaluating the pathological grade of solid lung adenocarcinoma. Clinical Radiology. 79(4). 279–286. 2 indexed citations
7.
Jiang, Hong, Chang–Xing Huang, Fuchun Zhang, et al.. (2022). Expert Consensus on the Prevention and Treatment of Hemorrhagic Fever with Renal Syndrome. SHILAP Revista de lepidopterología. 2(4). 224–232. 11 indexed citations
8.
Wang, Yikai, et al.. (2022). A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology. 2022. 1–15. 40 indexed citations
9.
10.
11.
Zhang, Xin, Shuangsuo Dang, Fanpu Ji, et al.. (2018). Seasonality of cellulitis: evidence from Google Trends. Infection and Drug Resistance. Volume 11. 689–693. 25 indexed citations
12.
Wei, Bin, Fanpu Ji, Yee Hui Yeo, et al.. (2018). Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia. BMJ Open Gastroenterology. 5(1). e000209–e000209. 11 indexed citations
13.
14.
15.
Zhang, Xin, et al.. (2016). [Oestrogen inhibits invasion and metastasis of hepatocellular carcinoma MHCC97H cells by regulating the activity of AKT signaling pathway].. PubMed. 36(12). 1621–1625.
16.
Liu, Jingkun, Linbang Wang, Wenjun Wang, et al.. (2016). Application of network construction to estimate functional changes to insulin receptor substrates 1 and 2 in Huh7 cells following infection with the hepatitis C virus. Molecular Medicine Reports. 14(3). 2379–2388. 1 indexed citations
17.
Ji, Fanpu, Shuangsuo Dang, Zhifang Cai, et al.. (2015). [Antiviral treatment and long-term clinical outcome of decompensated cirrhotic patients with hepatitis C virus infection].. PubMed. 23(9). 647–52. 4 indexed citations
18.
Wang, Wenjun, et al.. (2013). hOGG1 Ser326Cys Polymorphism and Risk of Hepatocellular Carcinoma among East Asians: A Meta-Analysis. PLoS ONE. 8(4). e60178–e60178. 19 indexed citations
19.
Liu, Jingkun, et al.. (2012). Computational networks of activating transcription factor 3 gene in Huh7 cell lines and hepatitis C virus-infected Huh7 cell lines. Molecular Medicine Reports. 12(1). 1239–1246. 4 indexed citations
20.
Dang, Shuangsuo, Wenjun Wang, Xiufang Wang, et al.. (2011). Telaprevir for Chronic Hepatitis C with Genotype 1: A Meta-Analysis. Hepatogastroenterology. 59(114). 461–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wafaa M. Ezzat Breakdown of academic impact, for papers by Jianhong Chen Breakdown of academic impact, for papers by Kohei Oda Breakdown of academic impact, for papers by Ruoting Men Breakdown of academic impact, for papers by Chao Ou Breakdown of academic impact, for papers by Qiang Ji Breakdown of academic impact, for papers by Wei-Hong Yang Breakdown of academic impact, for papers by José María Vera-Cruz Breakdown of academic impact, for papers by Xiaohui Tian Breakdown of academic impact, for papers by Kotaro Kumagai
Rankless by CCL
2026